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Background: The purpose of this study was to develop novel sandwich-structured nanofibrous 
membranes to provide sustained-release delivery of vancomycin, gentamicin, and lidocaine for 
repair of infected wounds.
Methods: To prepare the biodegradable membranes, poly(D, L)-lactide-co-glycolide (PLGA), 
collagen, and various pharmaceuticals, including vancomycin, gentamicin, and lidocaine, were 
first dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol. They were electrospun into sandwich-
structured membranes with PLGA/collagen as the surface layers and PLGA/drugs as the core. 
An elution method and a high-pressure liquid chromatography assay were used to characterize 
in vivo and in vitro drug release from the membranes. In addition, repair of infected wounds 
in rats was studied. Histological examination of epithelialization and granulation at the wound 
site was also performed.
Results: The biodegradable nanofibrous membranes released large amounts of vancomycin and 
gentamicin (well above the minimum inhibition concentration) and lidocaine in vivo for more 
than 3 weeks. A bacterial inhibition test was carried out to determine the relative activity of the 
antibiotics released. The bioactivity ranged from 40% to 100%. The nanofibrous membranes 
were functionally active in treating infected wounds, and were very effective as accelerators in 
early-stage wound healing.
Conclusion: Using the electrospinning technique, we will be able to manufacture biodegradable, 
biomimetic, nanofibrous, extracellular membranes for long-term delivery of various drugs.
Keywords: nanofibrous, sandwich-structured, drug-eluting membranes, electrospinning, release 
characteristics, repair, wound infection
Introduction
Prompt closure of full thickness wounds is critical to survival after severe burns 
injuries. The risk of infection is of great concern with deep burn wounds, and is 
likely due to the combination of impaired local immunity with the presence of dead 
tissue and impaired systemic immunity with such extensive injury.1,2 Development 
of a wound infection depends on a complex interplay of many factors. If the integ-
rity and protective function of the skin is breached, large quantities of different cell 
types will enter the wound and initiate an inflammatory response. This is typically 
characterized by the classic signs of redness, pain, swelling, raised temperature, and 
fever. Treatment measures for an infected wound include administration of antibiotics, 
removing necrotic tissue, and cleansing wounds to minimize colonization. Wound 
dressing is essential for the prevention of infection. An ideal candidate for dressing 
of infectious wounds should deliver sufficiently high concentration of antibiotics to 
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the wound site; mimic the structure and biological function 
of native extracellular matrix proteins, which provide sup-
port and regulate cellular activities; maintain the normal 
state of differentiation within the cellular compartment; be 
biocompatible and/or biodegradable; and have no adverse 
effects on the surrounding tissue.
Commercial wound dressings that exert their antimi-
crobial effect by eluting germicidal compounds have been 
developed to provide sustained release of therapeutic doses 
of silver ions to the wound. However, silver ions are highly 
toxic to keratinocytes and fibroblasts, and may delay wound 
repair if applied indiscriminately to healing tissue areas. In 
addition, constant wound cleaning and redressing is needed, 
causing discomfort to patients and requiring substantial nurs-
ing input. A biodegradable drug-eluting wound dressing from 
an electrospun nanofibrous matrix potentially offers several 
advantages over conventional ones.3–5
Various efforts have been made to develop drug-eluting 
dressings. Mi et al6 proposed a bilayered chitosan membrane, 
consisting of a dense skin layer and a sponge-like sublayer for 
topical delivery of silver sulfadiazine. Peng et al7 developed 
paracetamol-loaded poly(D,L-lactide) and poly(ethylene 
glycol)-co-poly(D,L, lactide) fibers that provide sustained 
drug release in vitro. Elsner and Zilberman and Elsner et al8,9 
fabricated antibiotic-eluting composite fibers that consisted of 
a polyglyconate core and a porous poly(D,L-lactic-co-glycolic 
acid) (PLGA) shell as basic dressing elements that use 
freeze-drying of invert emulsions. Teo et al10 developed a 
three-dimensional polycaprolactone-tricalcium phosphate 
mesh for delivery of gentamicin sulfate to infected wounds. 
Meng et al11,12 prepared PLGA/gelatin and PLGA/chitosan 
nanofibers for delivery of fenbufen via the electrospinning 
process. Recently, Kontogiannopoulos et al13 prepared 
electrospun fiber mats containing shikonin and derivatives, 
using four biocompatible polymers, including cellulose acetate, 
poly(L-lactide), and 50/50 and 75/25 LA/GA poly(lacide-co-
glycolide). Sandwich-structured drug-eluting dressings made 
of biodegradable nanofibers, with collagen as the surface 
layers and drugs (antibiotics and anesthetics) at the core, can 
provide advantages over single-layer dressings. In addition to 
the delivery of a sustainable antimicrobial concentration to the 
wound site, the surface layer of electrospun sandwich-  structured 
collagen nanofibers, with its large area and microporous 
structure, is able to promote wound healing.14–19 Further, the 
nanofibrous membrane is also important for cell attachment 
and proliferation in wound healing.20 Nevertheless, there has 
not been any previous development of sandwich-structured 
membranes for the delivery of pharmaceuticals.
This study developed biodegradable, sandwich-  structured, 
nanofibrous, drug-eluting membranes (DEM) via electrospin-
ning21 for dressing of infected wounds. In addition to car-
rying pharmaceuticals, PLGA is nontoxic, elicits a minimal 
inflammatory response, and can be eventually absorbed 
without any accumulation in the vital organs.22,23 Collagen 
is a principal structural component of the extracellular 
matrix. After   electrospinning, the morphology of the elec-
trospun nanofibers was characterized by scanning electron 
  microscopy. The in vitro and in vivo release characteristics of 
the pharmaceuticals from the membranes was investigated. 
A bacterial inhibition test was carried out to determine the 
relative activity of the antibiotics released. In addition, the 
effect of nanofibrous DEM on repair of infected wounds in 
rats was examined. Histological examination of epithelializa-
tion and granulation at the wound site was also performed.
Materials and methods
Fabrication of nanofibrous membranes
The PLGA used in this study was a commercially   available 
material (Resomer RG 503, Boehringer, Ingelheim,   Germany) 
with a lactide:glycolide ratio of 50:50 and an intrinsic 
  viscosity of 0.4. Type I collagen from bovine   Achilles 
tendon and 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) were 
purchased from Sigma-Aldrich (Saint Louis, MO). The drugs 
used were vancomycin hydrochloride, gentamicin sulfate, 
and lidocaine hydrochloride (Sigma-Aldrich), all of which 
were of   commercial grade.
The electrospinning apparatus used in this study   consisted 
of a syringe and needle (internal diameter 0.42 mm), a 
ground electrode, an aluminum sheet, and a high voltage 
power supply,20 as shown schematically in Figure 1. The 
needle was connected to the high voltage supply, which 
generated positive DC voltages and currents up to 35 kV and 
4.16 mA/125 W, respectively. To prepare the membranes, 
PLGA and collagen (280 mg and 140 mg, respectively) 
were first dissolved in 1 mL of HFIP, while the PLGA, 
  vancomycin, gentamicin, and lidocaine (960, 140, 140, and 
140 mg, respectively) were dissolved in 4 mL of HFIP.
Two types of membranes were prepared, ie, drug-eluting 
membranes (DEM) and non-drug-eluting membranes 
(NDEM). For electrospinning of DEM, 1 mL of PLGA/ 
  collagen solution was delivered and electrospun using a 
syringe pump with a volumetric flow rate of 3.6 mL/hour for 
the surface layer, followed by electrospinning of 4 mL PLGA/
vancomycin/gentamicin/lidocaine solution with a volumetric 
flow rate of 1.2 mL/hour for the core layer, and finally by 
spinning of another 1 mL of PLGA/collagen solution for the 
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second surface layer. Sandwich-structured membranes, with 
PLGA/collagen as the surface layer and PLGA/drugs at the 
core, with a thickness of 0.107 mm, were thus obtained. For 
the preparation of NDEM, 5 mL of PLGA/collagen solution 
was delivered and electrospun using a syringe pump, with a 
volumetric flow rate of 3.6 mL/hour, to obtain a membrane 
0.110 mm in thickness. The distance between the needle tip 
and the ground electrode was 12 cm, and the positive voltage 
applied to the polymer solutions was 17 kV . All electrospin-
ning experiments were carried out at room temperature.
Mechanical properties
The tensile strengths of the PLGA/collagen membranes 
fabricated were determined. The dumbbell-shaped tensile 
specimens with gauge lengths of 20 mm and cross-sectional 
areas of 10 mm × 0.4 mm (width by thickness) were obtained 
from the nanofibrous membranes using a knife. Tensile 
tests were performed using a Lloyd tensiometer, along with 
the ASTM D638 test. A 100 N load cell was used and the 
crosshead speed was 90 mm/minute.
Standard curve
A high-performance liquid chromatography (HPLC) 
assay was used to determine standard drug concentration 
curves. The HPLC analyses were conducted on a Hitachi 
L-2200 multisolvent delivery system. A Symmetry C8, 
3.9 cm × 150 mm HPLC column (Waters, Milford, MA) 
was used for separation of vancomycin. The mobile phase 
contained 0.01 mol heptanesulfonic acid (Fisher Scientific 
UK Ltd, Loughborough, UK) and acetonitrile (85/15, v/v, 
Mallinckrodt, St Louis, MO). Absorbency was monitored at a 
wavelength of 280 nm, and the flow rate was 1.4 mL/minute. 
All experiments were carried out in triplicate and the sample 
dilutions were performed to bring the unknown concentra-
tions into the range of the standard assay curve. A calibration 
curve was made for each set of measurements (correlation 
coefficient . 0.99). The elution product could be specifically 
identified and quantified with high sensitivity using the HPLC 
system. Concentrations of eluted gentamicin and lidocaine 
were also determined using the same HPLC assay.
In vitro release of pharmaceuticals
The release characteristics of vancomycin, gentamicin, and 
lidocaine from the nanofibrous membrane were determined 
using the in vitro elution method. Samples with an area of 
2 cm × 3 cm, cut from the electrospun membranes, were 
placed in glass test tubes (one sample per test tube, total 
number = 3) with 1 mL of phosphate-buffered solution 
(0.15 mol/L, pH 7.4) in each. The glass test tubes were 
incubated at 37°C for 24 hours, after which the eluent was 
collected and analyzed. Fresh phosphate-buffered solution 
(1 mL) was added for the following 24-hour period, and the 
procedure was repeated for 30 days. Drug concentrations 
in the eluents were determined using the standard HPLC 
assay curve.
Healing of wound infection test
Twelve Sprague-Dawley rats weighing 375 ± 25 g were 
used in this study. After induction of anesthesia, two full-
thickness 2 cm × 2 cm rectangular wounds were cut into 
each rat’s back, parallel with the vertebral column. All 
animal procedures received institutional approval, and all 
animals used in the study were cared for in accordance 
with the regulations of the National Institute of Health of 
the Republic of China, Taiwan, under the supervision of a 
licensed veterinarian. Following the work of Grzybowski 
et al,24 standard strains of Staphylococcus aureus (ATCC 
65389) and Escherichia coli (ATCC 23815), provided by 
the Bioresource Collection and Research Center of Taiwan, 
were used in this study. A 10 µL sample of bacteria inoculum 
was cultured in 5 mL of nutrient broth and grown overnight 
at 37°C with constant shaking at 200 rpm. The concentration 
of bacterial suspension was adjusted using ultraviolet-visible 
spectrophotometry (Opron-3000) at 200–600 nm. The final 
concentrations of the prepared S. aureus and E. coli media 
were about 106/µL each. Bacterial suspensions were diluted 
with 0.9% sterile saline, and the final concentrations were 
1 × 106 colony-forming units per 100 µL. The rats then 
received a topical application of 1 × 106 colony-forming 
units of both S. aureus and E. coli in 100 µL and were left for 
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Figure 1 Electrospinning apparatus.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
765
Nanofibrous drug-eluting membranesInternational Journal of Nanomedicine 2012:7
24 hours for infection to develop.25 All rats were divided into 
three groups, ie, three rats in group A, six rats in group B, 
and three rats in group C. The electrospun NDEM (PLGA/
collagen matrix) was applied to the infected wounds of each 
rat in group A, while the DEM (PLGA/collagen/antibiotic) 
was applied to the infected wounds of each rat in group B. 
The rats in group C were treated with conventional gauze 
sponge as the control. No dressings were replaced and no 
topical drugs were applied during the entire healing process. 
Intradermal (beneath the dressings) tapping using 19-gauge 
needle aspiration was performed on days 1, 3, 7, 14, and 
21 in three group B rats (wounds treated with DEM) for in 
vivo release analysis. On postoperative days 7, 14, and 21, 
macroscopic photographs of the wounds were taken. Further, 
the wound dressings on the other three rats were removed on 
postoperative days 7, 14, and 21 for histological examination 
of epithelialization and granulation.
In vivo release behavior
The concentrations of antibiotics and lidocaine in the tapped 
fluid were measured by HPLC on a Hitachi L-2200 multisol-
vent delivery system. All tapping samples were assayed after 
dilution with phosphate-buffered solution and assessed using 
the standard assay curve. A calibration curve was made for 
each set of measurements (correlation coefficient . 0.99).
The relative antibiotic activity of the collected fluid 
was determined using the disk diffusion method in nutrient 
broth (beef extract, Peptone, Difco Laboratories, Detroit, 
MI). Eight microliters of eluent were pipetted onto 6 mm 
absorption disks. The disks were placed on nutrient agar 
plates seeded with a layer of S. aureus. The inhibition zones 
were measured within a micrometer after 16–18 hours of 
incubation at 35°C. A 50 µg/mL drug solution was used as 
a reference. The relative activity of the vancomycin released 
was defined as: 
relative activity (%) = (diameter of sample inhibition 
zone)/(diameter of reference inhibition zone) × 100.
The bioactivity of gentamicin on E. coli was determined 
by the same method.
Scanning electron microscopic 
observation
The morphology of the electrospun nanofibers was observed 
under a scanning electron microscope (Hitachi S-3000N, 
Japan) after gold coating. The average diameter and size 
distribution were determined by analyzing the scanning elec-
tron microscopic images using a commercial image analysis 
program (Optimas version 5.22).
Statistics and data analysis
Data were collected from quadruplicate samples and analyzed 
by one-way analysis of variance. Differences were considered 
statistically significant at P values ,0.05.
Results and discussion
Electrospinning of DEM
In this study, sandwich-structured DEM with PLGA/collagen 
surface layers and a PLGA/drug core layer were successfully 
fabricated via the electrospinning technique. During the 
electrospinning process, a polymeric solution placed inside 
a syringe is driven out from a metal capillary connected to a 
high voltage power supply. Nanofibers are collected in the 
form of a nonwoven matrix on a grounded collector after 
solvent evaporation. Continuous PLGA, collagen, and phar-
maceutical nanofibers were obtained at concentrations that 
corresponded to the onset of significant chain entanglements 
in the polymers. The influence of processing parameters on 
the distribution of the fiber diameters was investigated. It was 
found that the fiber diameter decreased with the content of 
drugs and collagen in the blended solutions.20 Furthermore, 
the diameter of the electrospun fibers increased to some 
extent with voltage and distance between the needle and 
its target.
By adopting appropriate process parameters (such as 
solvent, polymer concentration, and flow rate), electrospun 
sandwich-structured nanofibrous membranes could be 
obtained. Figure 2 shows scanning electron micrographs of 
the electrospun nanofibers under magnification at 20,000×. 
The surface PLGA/collagen layers (Figure 2A and C) showed 
a greater diameter distribution than the core PLGA/drug layer 
(Figure 2B), attributable mainly to the presence of collagen 
in the blended solutions. The diameters of the spun PLGA/
collagen and PLGA/drug nanofibers ranged from 55 nm to 
222 nm and from 185 nm to 314 nm, respectively, and the 
porosity of the nanofibrous membrane was high.
The mechanical properties of the electrospun nanofibrous 
membranes were determined. Figure 3 shows the measured 
stress-strain curves for the prepared PLGA/collagen mem-
branes. The tensile strength and elongation at break were 
measured to be 1.13 MPa and 116%, respectively. The nano-
fibrous membranes produced by electrospinning were shown 
to have the mechanical characteristics needed for application 
as a wound dressing.
In vitro and in vivo drug release
Daily in vitro release curves for vancomycin, gentamicin, and 
lidocaine are shown in Figure 4. All drugs showed a triphasic 
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release pattern, with an abrupt initial burst phase on day 1. 
After the electrospinning process, most of the drugs were dis-
persed in the bulk of the PLGA matrix; however, some drug 
particles and crystals might have been located on the surface 
of the nanofibers. This led to the initial burst of drug release. 
Following the initial burst, drug release was controlled solely 
by diffusion. A second peak of release was observed in 
week 2, and the concentration gradually decreased thereafter. 
Further, the biodegradable DEM released high concentrations 
of Gram-positive vancomycin and Gram-negative gentami-
cin, well above the 90% minimum inhibitory concentration 
(MIC90)26,27 for 24 and 23 days, respectively. The membrane 
also eluted lidocaine for 15 days.
In vivo drug levels were measured over 3 weeks 
using the HPLC assay, and the concentrations are shown 
in Figures 5–7. All drugs showed biphasic release and 
peaked at day 14 (vancomycin 310.87 µg/mL, gentamicin 
1729.50 µg/mL, and lidocaine 648.40 µg/mL), and thereafter 
the cumulative concentration dropped progressively. The 
in vivo antibiotic concentrations remained well above the 
IC90 for at least 3 weeks (Figures 5 and 6), and for lidocaine, 
the concentration was still high at week 3 (Figure 7). In 
addition, the bioactivity of the released antibiotics remained 
high, ranging between 40% and 90% and 45% and 100% 
for vancomycin and gentamicin, respectively, as shown in 
Figures 5 and 6.
Wound healing and histological 
examination
To test for healing of infected wounds, two full-thickness 
rectangular wounds were cut into the back of each rat. 
The rats then underwent topical application of 1 × 106 
colony-forming units of S. aureus and E. coli in 100 µL, 
followed by coverage with DEM, NDEM, or gauze sponge. 
  Figure 8 shows the animals from each group at weeks 1, 2, 
and 3 after grafting. All four rats in group C (control rats, 
infected wounds covered only by gauze) died within the 
first week after grafting. Only rats from group A (wound 
Figure 2 Scanning electron microscopic images of electrospun, sandwich-structured 
nanofibers. (A) Top PLGA/collagen layer, (B) PLGA/vancomycin/gentamycin/lidocaine 
at the core, and (C) bottom PLGA/collagen layer.
Abbreviation: PLGA, poly(D, L)-lactide-co-glycolide.
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covered by NDEM) and group B (wound covered by DEM) 
are shown in the graph.
In the first week after grafting, the gross wound 
appearance in rats with NDEM-covered wounds was 
similar to that in the rats with DEM-covered wounds 
(Figure 8A1 and B1). In the second week, necrotic tissue 
combined with frank pus formation were noted in rats 
with NDEM-covered wounds (Figure 8A2), and in con-
trast, clear soft tissue with neovascularization were noted 
in rats with DEM-covered wounds (Figure 8B2). In the 
third week after grafting, the wound state was worsening 
in the rats with NDEM-covered wounds (Figure 8A3). 
However, the wound healing process was almost complete 
in the rats with DEM-covered wounds (Figure 8B3). 
  Further, the grafts prepared with DEM scaffolds were well 
integrated into the surrounding skin. Electrospun DEM 
appeared to be more effective than NDEM in promoting 
wound healing. The wound area covered by electrospun 
DEM decreased to approximately 25% at 21 days.
The images from histological examination shown in 
Figure 9 demonstrate that the DEM dressings had a better 
healing effect than NDEM dressings on infected wounds. 
In the first week after grafting, there was no discernible 
difference between histological sections of wounds treated 
by NDEM and DEM dressings (Figure 9A1 and B1), all 
showing an ulcerated surface, formation of granulation tis-
sue, and infiltration with inflammatory cells. In the second 
and third weeks after grafting, the wounds treated with a 
DEM dressing (Figure 9B2 and B3) were healing, with 
newly synthesized fibrous tissue and sparse inflammatory 
cells in the dermis and subcutis, covered by a completely 
  re-epithelialized epidermis. In contrast, the wounds treated 
with an NDEM dressing (Figure 9A2 and A3) showed incom-
plete re-epithelialization and prominent inflammatory cell 
infiltration. This confirms further that electrospun DEM can 
be a suitable tissue-engineering scaffold for repair of infected 
wounds and skin regeneration.
The bactericidal effects of the antibiotics incorporated 
into the biodegradable membrane far outweigh any negative 
inherent effects of the membrane itself.28 Local antibiotics 
and anesthetics have the advantage of delivering high drug 
concentrations to the precise area required, and the total drug 
dose applied locally is not normally sufficient to produce 
toxic systemic effects. Despite the possibility of the antimi-
crobial and anesthetic agents released from the nanofibers 
harming viable tissue and delaying cell growth and prolifera-
tion during the healing process, the potential impact of the 
drugs released on cell proliferation gradually diminished in 
the 2 weeks following grafting (Figure 9).
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A1 A2 A3
B3 B2 B1
Figure 8 Appearance of wound healing at weeks 1, 2, and 3 after grafting. (A) PLGA/collagen group and (B) PLGA/collagen with vancomycin, gentamicin, and lidocaine group 
(rectangular wounds 2 cm × 2 cm were prepared on each rat’s back, as shown in A1 and B1).
Abbreviation: PLGA, poly(D, L)-lactide-co-glycolide.
A1
B1 B2 B3
A2 A3
Figure 9 Histological images of (A) PLGA/collagen group and (B) PLGA/collagen with vancomycin, gentamicin, and lidocaine group at weeks 1, 2, and 3. (No necrosis was 
observed in B3).
Abbreviation: PLGA, poly(D, L)-lactide-co-glycolide.
As a potential wound dressing scaffold for tissue engi-
neering, the nanofibrous matrix should promote cell growth 
and physiological function and should be able to maintain 
normal states of cell differentiation. The presence of col-
lagen in the PLGA/collagen nanofibers increases the wet-
tability of the electrospun matrices, which may promote 
cell proliferation in the matrices.29 In addition, collagen is 
a natural extracellular matrix component of many tissues, 
including skin, bone, tendon, ligament, and other connective 
tissues that promote wound healing. Despite previous reports 
of the electrospinning process denaturing the biological and 
structural properties of natural proteins such as collagen,18 
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our findings show that the PLGA/collagen nanofibrous matrix 
remains intact during electrospinning and can act as an 
excellent scaffold for cell growth and proliferation. Further, 
the bioactivity of vancomycin and gentamicin remains high 
after the electrospinning process, indicating that electrospun 
drug-eluting PLGA/collagen nanofibers are good candidates 
for dressings to assist in the repair of infected wounds.
Conclusion
In the present study, a sandwich-structured, nanofibrous, drug-
eluting matrix produced by electrospinning was formulated 
for use as a wound dressing. The experimental results show 
that the biodegradable nanofibrous membranes released high 
concentrations of vancomycin and gentamicin (well above the 
MIC90) and lidocaine in vivo for more than 3 weeks. The bio-
activity of the antibiotics released ranged from 40% to 100% 
of relative activity. In addition, repair of infected wounds in 
rats was studied. Histological examination of epithelialization 
and granulation at the wound site was also performed. It was 
found that nanofibrous membranes were functionally active in 
treating wound infections and were very effective as wound-
healing accelerators in the early stages of healing. By using 
the electrospinning technique, we may be able to manufacture 
biodegradable, biomimetic, nanofibrous, extracellular mem-
branes for long-term delivery of a range of medicines.
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